FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely dermatology and immunology. Use of Laennek as immunotropic preparation is disclosed for treating a disease, associated with impaired immunity, which is chronic recurrent herpes, atopic dermatitis or psoriasis, by drop intravenous introduction of Laennek 2 times a week in an amount of 10 procedures during integrated therapy, where the first drop introduction to patient is 4.0 ml Laennek dissolved in 200-250 ml of saline solution (0.9 % aqueous solution of sodium chloride) through ulnar vein for 1 hour 20 minutes, second and subsequent introduction contain 10.0 ml of Laennek dissolved in 250 ml of 0.9 % saline solution through ulnar vein for 1.5 hours.
EFFECT: use of Laennek as immunotropic preparation is disclosed for treating a disease, associated with impaired immunity, which is chronic recurrent herpes, atopic dermatitis or psoriasis.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT AND REHABILITATION OF HUMAN ORGANISM | 2012 |
|
RU2488376C1 |
METHOD OF TREATING ACUTE HEPATITIS B OR C WITH SEVERE CLINICAL COURSE | 2015 |
|
RU2599037C1 |
METHOD OF PREDICTING INFECTIOUS COMPLICATIONS OF ATOPIC DERMATITIS | 2008 |
|
RU2350960C1 |
USE OF PREPARATION LAENNEK FOR TREATING CIRRHOSIS | 2015 |
|
RU2599040C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES BY AUTOLOGICAL LYMPHOCYTES | 2015 |
|
RU2633343C2 |
METHOD OF TREATING AND PREVENTING AGE-ASSOCIATED DISEASES | 2018 |
|
RU2709488C1 |
METHOD FOR COMPLEX EXPOSURE ON NEURAL-REFLEX ITCHING MECHANISMS IN PATIENTS WITH ATOPIC DERMATITIS | 2013 |
|
RU2523634C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE AND EVALUATION OF CLINICAL EFFECTIVENESS OF ATOPIC DERMATITIS TREATMENT | 2015 |
|
RU2603463C1 |
METHOD FOR TREATMENT OF ORAL MUCOSA CHRONIC INFLAMMATION WITH HYPERKERATOSIS ELEMENTS IN YOUNG PERSONS | 2016 |
|
RU2637413C1 |
METHOD FOR LASER THERAPY OF PATIENTS WITH ATOPIC DERMATITIS | 2014 |
|
RU2562317C1 |
Authors
Dates
2016-10-10—Published
2015-10-22—Filed